nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Sorafenib—thyroid cancer	0.157	0.252	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—thyroid cancer	0.0955	0.153	CbGbCtD
Mexiletine—CYP1A2—Sorafenib—thyroid cancer	0.0923	0.148	CbGbCtD
Mexiletine—CYP3A4—Vandetanib—thyroid cancer	0.0802	0.128	CbGbCtD
Mexiletine—CYP2D6—Sorafenib—thyroid cancer	0.076	0.122	CbGbCtD
Mexiletine—CYP3A4—Sorafenib—thyroid cancer	0.0483	0.0773	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—thyroid cancer	0.0461	0.0738	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—thyroid cancer	0.0293	0.0469	CbGbCtD
Mexiletine—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0101	0.0277	CcSEcCtD
Mexiletine—Cardiogenic shock—Epirubicin—thyroid cancer	0.00892	0.0244	CcSEcCtD
Mexiletine—Cardiogenic shock—Doxorubicin—thyroid cancer	0.00825	0.0225	CcSEcCtD
Mexiletine—Oesophageal ulcer—Epirubicin—thyroid cancer	0.00512	0.014	CcSEcCtD
Mexiletine—Dry skin—Vandetanib—thyroid cancer	0.00499	0.0136	CcSEcCtD
Mexiletine—Oesophageal ulcer—Doxorubicin—thyroid cancer	0.00474	0.0129	CcSEcCtD
Mexiletine—Dysphagia—Vandetanib—thyroid cancer	0.0047	0.0128	CcSEcCtD
Mexiletine—Pancreatitis—Vandetanib—thyroid cancer	0.00461	0.0126	CcSEcCtD
Mexiletine—Neutropenia—Vandetanib—thyroid cancer	0.0044	0.012	CcSEcCtD
Mexiletine—Depression—Vandetanib—thyroid cancer	0.00418	0.0114	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00416	0.0114	CcSEcCtD
Mexiletine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00405	0.0111	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00389	0.0106	CcSEcCtD
Mexiletine—Bradycardia—Vandetanib—thyroid cancer	0.00383	0.0105	CcSEcCtD
Mexiletine—Visual impairment—Vandetanib—thyroid cancer	0.00363	0.00991	CcSEcCtD
Mexiletine—Erythema multiforme—Vandetanib—thyroid cancer	0.00356	0.00972	CcSEcCtD
Mexiletine—Dry skin—Sorafenib—thyroid cancer	0.00336	0.00919	CcSEcCtD
Mexiletine—Arrhythmia—Vandetanib—thyroid cancer	0.00336	0.00919	CcSEcCtD
Mexiletine—Alopecia—Vandetanib—thyroid cancer	0.00333	0.00909	CcSEcCtD
Mexiletine—Dysgeusia—Vandetanib—thyroid cancer	0.00321	0.00877	CcSEcCtD
Mexiletine—Dysphagia—Sorafenib—thyroid cancer	0.00317	0.00867	CcSEcCtD
Mexiletine—Muscle spasms—Vandetanib—thyroid cancer	0.00315	0.00861	CcSEcCtD
Mexiletine—Pancreatitis—Sorafenib—thyroid cancer	0.00311	0.0085	CcSEcCtD
Mexiletine—Vision blurred—Vandetanib—thyroid cancer	0.00309	0.00844	CcSEcCtD
Mexiletine—Tremor—Vandetanib—thyroid cancer	0.00307	0.00839	CcSEcCtD
Mexiletine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00304	0.00831	CcSEcCtD
Mexiletine—Neutropenia—Sorafenib—thyroid cancer	0.00297	0.0081	CcSEcCtD
Mexiletine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00292	0.00798	CcSEcCtD
Mexiletine—Loss of consciousness—Vandetanib—thyroid cancer	0.00288	0.00787	CcSEcCtD
Mexiletine—Convulsion—Vandetanib—thyroid cancer	0.00284	0.00776	CcSEcCtD
Mexiletine—Hypertension—Vandetanib—thyroid cancer	0.00283	0.00773	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.0028	0.00766	CcSEcCtD
Mexiletine—Chest pain—Vandetanib—thyroid cancer	0.00279	0.00762	CcSEcCtD
Mexiletine—Arthralgia—Vandetanib—thyroid cancer	0.00279	0.00762	CcSEcCtD
Mexiletine—Dry mouth—Vandetanib—thyroid cancer	0.00273	0.00745	CcSEcCtD
Mexiletine—Oedema—Vandetanib—thyroid cancer	0.00267	0.00731	CcSEcCtD
Mexiletine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00262	0.00715	CcSEcCtD
Mexiletine—Nystagmus—Epirubicin—thyroid cancer	0.00262	0.00715	CcSEcCtD
Mexiletine—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00252	0.0069	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00244	0.00666	CcSEcCtD
Mexiletine—Nystagmus—Doxorubicin—thyroid cancer	0.00242	0.00661	CcSEcCtD
Mexiletine—Paraesthesia—Vandetanib—thyroid cancer	0.0024	0.00656	CcSEcCtD
Mexiletine—Erythema multiforme—Sorafenib—thyroid cancer	0.0024	0.00656	CcSEcCtD
Mexiletine—Dyspnoea—Vandetanib—thyroid cancer	0.00238	0.00651	CcSEcCtD
Mexiletine—Tinnitus—Sorafenib—thyroid cancer	0.00237	0.00647	CcSEcCtD
Mexiletine—Dyspepsia—Vandetanib—thyroid cancer	0.00235	0.00643	CcSEcCtD
Mexiletine—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00234	0.00638	CcSEcCtD
Mexiletine—Fatigue—Vandetanib—thyroid cancer	0.00231	0.0063	CcSEcCtD
Mexiletine—Pain—Vandetanib—thyroid cancer	0.00229	0.00625	CcSEcCtD
Mexiletine—Constipation—Vandetanib—thyroid cancer	0.00229	0.00625	CcSEcCtD
Mexiletine—Arrhythmia—Sorafenib—thyroid cancer	0.00227	0.0062	CcSEcCtD
Mexiletine—Alopecia—Sorafenib—thyroid cancer	0.00224	0.00613	CcSEcCtD
Mexiletine—Blood disorder—Epirubicin—thyroid cancer	0.00224	0.00611	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00219	0.00597	CcSEcCtD
Mexiletine—Dysgeusia—Sorafenib—thyroid cancer	0.00216	0.00591	CcSEcCtD
Mexiletine—Muscle spasms—Sorafenib—thyroid cancer	0.00213	0.00581	CcSEcCtD
Mexiletine—Abdominal pain—Vandetanib—thyroid cancer	0.00211	0.00578	CcSEcCtD
Mexiletine—Body temperature increased—Vandetanib—thyroid cancer	0.00211	0.00578	CcSEcCtD
Mexiletine—Blood disorder—Doxorubicin—thyroid cancer	0.00207	0.00566	CcSEcCtD
Mexiletine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00207	0.00565	CcSEcCtD
Mexiletine—Syncope—Sorafenib—thyroid cancer	0.00198	0.00542	CcSEcCtD
Mexiletine—Leukopenia—Sorafenib—thyroid cancer	0.00198	0.00541	CcSEcCtD
Mexiletine—Loss of consciousness—Sorafenib—thyroid cancer	0.00194	0.00531	CcSEcCtD
Mexiletine—Atrioventricular block—Epirubicin—thyroid cancer	0.00193	0.00526	CcSEcCtD
Mexiletine—Asthenia—Vandetanib—thyroid cancer	0.00192	0.00524	CcSEcCtD
Mexiletine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00191	0.00523	CcSEcCtD
Mexiletine—Hypertension—Sorafenib—thyroid cancer	0.00191	0.00521	CcSEcCtD
Mexiletine—Coordination abnormal—Epirubicin—thyroid cancer	0.0019	0.0052	CcSEcCtD
Mexiletine—Arthralgia—Sorafenib—thyroid cancer	0.00188	0.00514	CcSEcCtD
Mexiletine—Hiccups—Epirubicin—thyroid cancer	0.00187	0.00511	CcSEcCtD
Mexiletine—Dry mouth—Sorafenib—thyroid cancer	0.00184	0.00503	CcSEcCtD
Mexiletine—Diarrhoea—Vandetanib—thyroid cancer	0.00183	0.005	CcSEcCtD
Mexiletine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00178	0.00487	CcSEcCtD
Mexiletine—Shock—Sorafenib—thyroid cancer	0.00177	0.00485	CcSEcCtD
Mexiletine—Dizziness—Vandetanib—thyroid cancer	0.00177	0.00483	CcSEcCtD
Mexiletine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00177	0.00483	CcSEcCtD
Mexiletine—Coordination abnormal—Doxorubicin—thyroid cancer	0.00176	0.00481	CcSEcCtD
Mexiletine—Hiccups—Doxorubicin—thyroid cancer	0.00173	0.00472	CcSEcCtD
Mexiletine—Vomiting—Vandetanib—thyroid cancer	0.0017	0.00465	CcSEcCtD
Mexiletine—Rash—Vandetanib—thyroid cancer	0.00169	0.00461	CcSEcCtD
Mexiletine—Dermatitis—Vandetanib—thyroid cancer	0.00168	0.0046	CcSEcCtD
Mexiletine—Headache—Vandetanib—thyroid cancer	0.00168	0.00458	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00164	0.00449	CcSEcCtD
Mexiletine—Dyspnoea—Sorafenib—thyroid cancer	0.00161	0.00439	CcSEcCtD
Mexiletine—Nausea—Vandetanib—thyroid cancer	0.00159	0.00434	CcSEcCtD
Mexiletine—Dyspepsia—Sorafenib—thyroid cancer	0.00159	0.00434	CcSEcCtD
Mexiletine—Fatigue—Sorafenib—thyroid cancer	0.00156	0.00425	CcSEcCtD
Mexiletine—Constipation—Sorafenib—thyroid cancer	0.00154	0.00421	CcSEcCtD
Mexiletine—Pain—Sorafenib—thyroid cancer	0.00154	0.00421	CcSEcCtD
Mexiletine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.0015	0.00409	CcSEcCtD
Mexiletine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00148	0.00403	CcSEcCtD
Mexiletine—Hot flush—Epirubicin—thyroid cancer	0.00145	0.00396	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00144	0.00393	CcSEcCtD
Mexiletine—Menopausal symptoms—Epirubicin—thyroid cancer	0.00144	0.00393	CcSEcCtD
Mexiletine—Abdominal pain—Sorafenib—thyroid cancer	0.00143	0.0039	CcSEcCtD
Mexiletine—Body temperature increased—Sorafenib—thyroid cancer	0.00143	0.0039	CcSEcCtD
Mexiletine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00138	0.00378	CcSEcCtD
Mexiletine—Hot flush—Doxorubicin—thyroid cancer	0.00134	0.00367	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00133	0.00363	CcSEcCtD
Mexiletine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00133	0.00363	CcSEcCtD
Mexiletine—Hypersensitivity—Sorafenib—thyroid cancer	0.00133	0.00363	CcSEcCtD
Mexiletine—Asthenia—Sorafenib—thyroid cancer	0.00129	0.00354	CcSEcCtD
Mexiletine—Ataxia—Epirubicin—thyroid cancer	0.00128	0.00348	CcSEcCtD
Mexiletine—Liver function test abnormal—Epirubicin—thyroid cancer	0.00125	0.00342	CcSEcCtD
Mexiletine—Dry skin—Epirubicin—thyroid cancer	0.00124	0.0034	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00123	0.138	CbGpPWpGaD
Mexiletine—Diarrhoea—Sorafenib—thyroid cancer	0.00123	0.00337	CcSEcCtD
Mexiletine—Dizziness—Sorafenib—thyroid cancer	0.00119	0.00326	CcSEcCtD
Mexiletine—Ataxia—Doxorubicin—thyroid cancer	0.00118	0.00322	CcSEcCtD
Mexiletine—Dysphagia—Epirubicin—thyroid cancer	0.00117	0.0032	CcSEcCtD
Mexiletine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00116	0.00317	CcSEcCtD
Mexiletine—Dry skin—Doxorubicin—thyroid cancer	0.00115	0.00314	CcSEcCtD
Mexiletine—Pancreatitis—Epirubicin—thyroid cancer	0.00115	0.00314	CcSEcCtD
Mexiletine—Vomiting—Sorafenib—thyroid cancer	0.00115	0.00313	CcSEcCtD
Mexiletine—Angina pectoris—Epirubicin—thyroid cancer	0.00114	0.00312	CcSEcCtD
Mexiletine—Rash—Sorafenib—thyroid cancer	0.00114	0.00311	CcSEcCtD
Mexiletine—Dermatitis—Sorafenib—thyroid cancer	0.00114	0.0031	CcSEcCtD
Mexiletine—Headache—Sorafenib—thyroid cancer	0.00113	0.00309	CcSEcCtD
Mexiletine—Neutropenia—Epirubicin—thyroid cancer	0.0011	0.003	CcSEcCtD
Mexiletine—Dysphagia—Doxorubicin—thyroid cancer	0.00108	0.00296	CcSEcCtD
Mexiletine—Nausea—Sorafenib—thyroid cancer	0.00107	0.00293	CcSEcCtD
Mexiletine—Pancreatitis—Doxorubicin—thyroid cancer	0.00106	0.00291	CcSEcCtD
Mexiletine—Angina pectoris—Doxorubicin—thyroid cancer	0.00106	0.00289	CcSEcCtD
Mexiletine—Drowsiness—Epirubicin—thyroid cancer	0.00105	0.00286	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00104	0.00283	CcSEcCtD
Mexiletine—Neutropenia—Doxorubicin—thyroid cancer	0.00101	0.00277	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—thyroid cancer	0.000975	0.00267	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—thyroid cancer	0.000967	0.00264	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000959	0.00262	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—thyroid cancer	0.000955	0.00261	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—thyroid cancer	0.000938	0.00256	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000934	0.00255	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—thyroid cancer	0.000931	0.00254	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—thyroid cancer	0.000904	0.00247	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000903	0.00247	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—thyroid cancer	0.000887	0.00242	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—thyroid cancer	0.000884	0.00242	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—thyroid cancer	0.000875	0.00239	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—thyroid cancer	0.000868	0.00237	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000864	0.00236	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—thyroid cancer	0.000862	0.00235	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—thyroid cancer	0.000838	0.00229	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—thyroid cancer	0.000837	0.00229	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—thyroid cancer	0.000829	0.00227	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000821	0.00224	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—thyroid cancer	0.00081	0.00221	CcSEcCtD
Mexiletine—Tension—Epirubicin—thyroid cancer	0.000802	0.00219	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—thyroid cancer	0.0008	0.00219	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—thyroid cancer	0.000793	0.00217	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—thyroid cancer	0.000785	0.00215	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—thyroid cancer	0.000776	0.00212	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—thyroid cancer	0.00077	0.0021	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—thyroid cancer	0.000767	0.0021	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000758	0.00207	CcSEcCtD
Mexiletine—Tension—Doxorubicin—thyroid cancer	0.000742	0.00203	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—thyroid cancer	0.00074	0.00202	CcSEcCtD
Mexiletine—Malaise—Epirubicin—thyroid cancer	0.000737	0.00201	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—thyroid cancer	0.000734	0.00201	CcSEcCtD
Mexiletine—Syncope—Epirubicin—thyroid cancer	0.000733	0.002	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—thyroid cancer	0.000731	0.002	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—thyroid cancer	0.000727	0.00199	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—thyroid cancer	0.000722	0.00197	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—thyroid cancer	0.000718	0.00196	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—thyroid cancer	0.000712	0.00195	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—thyroid cancer	0.000708	0.00193	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—thyroid cancer	0.000705	0.00193	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000701	0.00192	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—thyroid cancer	0.000695	0.0019	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—thyroid cancer	0.000695	0.0019	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—thyroid cancer	0.000687	0.00188	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—thyroid cancer	0.000682	0.00186	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—thyroid cancer	0.00068	0.00186	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—thyroid cancer	0.000678	0.00185	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—thyroid cancer	0.000677	0.00185	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—thyroid cancer	0.000672	0.00184	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—thyroid cancer	0.000668	0.00182	CcSEcCtD
Mexiletine—Oedema—Epirubicin—thyroid cancer	0.000667	0.00182	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000664	0.00182	CcSEcCtD
Mexiletine—Shock—Epirubicin—thyroid cancer	0.000656	0.00179	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—thyroid cancer	0.000655	0.00179	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000653	0.00178	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—thyroid cancer	0.000653	0.00178	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000644	0.00176	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—thyroid cancer	0.000643	0.00176	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—thyroid cancer	0.000643	0.00176	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—thyroid cancer	0.000636	0.00174	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—thyroid cancer	0.000629	0.00172	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—thyroid cancer	0.000623	0.0017	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—thyroid cancer	0.000622	0.0017	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—thyroid cancer	0.000617	0.00169	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000607	0.00166	CcSEcCtD
Mexiletine—Shock—Doxorubicin—thyroid cancer	0.000607	0.00166	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000604	0.00165	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—thyroid cancer	0.000599	0.00164	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000596	0.00163	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—thyroid cancer	0.000594	0.00162	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—thyroid cancer	0.000593	0.00162	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—thyroid cancer	0.000587	0.0016	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—thyroid cancer	0.000576	0.00157	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—thyroid cancer	0.000575	0.00157	CcSEcCtD
Mexiletine—Pain—Epirubicin—thyroid cancer	0.00057	0.00156	CcSEcCtD
Mexiletine—Constipation—Epirubicin—thyroid cancer	0.00057	0.00156	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000562	0.00154	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—thyroid cancer	0.000554	0.00151	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—thyroid cancer	0.00055	0.0015	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—thyroid cancer	0.000549	0.0015	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—thyroid cancer	0.000548	0.0015	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000545	0.00149	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—thyroid cancer	0.000543	0.00148	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—thyroid cancer	0.000532	0.00145	CcSEcCtD
Mexiletine—Pain—Doxorubicin—thyroid cancer	0.000528	0.00144	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—thyroid cancer	0.000528	0.00144	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—thyroid cancer	0.000527	0.00144	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—thyroid cancer	0.000527	0.00144	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000508	0.00139	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000504	0.00138	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—thyroid cancer	0.000491	0.00134	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—thyroid cancer	0.000488	0.00133	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—thyroid cancer	0.000488	0.00133	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—thyroid cancer	0.000478	0.00131	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—thyroid cancer	0.000456	0.00125	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000454	0.00124	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—thyroid cancer	0.000443	0.00121	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—thyroid cancer	0.000441	0.0012	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—thyroid cancer	0.000424	0.00116	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—thyroid cancer	0.000422	0.00115	CcSEcCtD
Mexiletine—Rash—Epirubicin—thyroid cancer	0.00042	0.00115	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—thyroid cancer	0.00042	0.00115	CcSEcCtD
Mexiletine—Headache—Epirubicin—thyroid cancer	0.000418	0.00114	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—thyroid cancer	0.000408	0.00111	CcSEcCtD
Mexiletine—Nausea—Epirubicin—thyroid cancer	0.000396	0.00108	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—thyroid cancer	0.000392	0.00107	CcSEcCtD
Mexiletine—Rash—Doxorubicin—thyroid cancer	0.000389	0.00106	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—thyroid cancer	0.000389	0.00106	CcSEcCtD
Mexiletine—Headache—Doxorubicin—thyroid cancer	0.000386	0.00106	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—NKX2-1—thyroid cancer	0.00037	0.0413	CbGpPWpGaD
Mexiletine—Nausea—Doxorubicin—thyroid cancer	0.000366	0.001	CcSEcCtD
Mexiletine—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000309	0.0346	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.0003	0.0335	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000242	0.0271	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—RXRA—thyroid cancer	0.000212	0.0237	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000194	0.0217	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000188	0.0211	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00018	0.0202	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000162	0.0181	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—HIF1A—thyroid cancer	0.000158	0.0176	CbGpPWpGaD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—NRG1—thyroid cancer	0.000157	0.0176	CbGpPWpGaD
Mexiletine—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000141	0.0157	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000139	0.0155	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000138	0.0154	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000136	0.0152	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—PPARG—thyroid cancer	0.000134	0.015	CbGpPWpGaD
Mexiletine—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000122	0.0136	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00012	0.0134	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000116	0.0129	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000108	0.012	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CHST14—thyroid cancer	0.000105	0.0118	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—SST—thyroid cancer	9.48e-05	0.0106	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—PPARG—thyroid cancer	9.46e-05	0.0106	CbGpPWpGaD
Mexiletine—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	9.43e-05	0.0105	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	8.46e-05	0.00945	CbGpPWpGaD
Mexiletine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	8.41e-05	0.0094	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	8.16e-05	0.00912	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	7.48e-05	0.00836	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—CDK1—thyroid cancer	7.39e-05	0.00825	CbGpPWpGaD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.37e-05	0.00824	CbGpPWpGaD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.33e-05	0.0082	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	7.22e-05	0.00807	CbGpPWpGaD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	7.18e-05	0.00803	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—CDK1—thyroid cancer	6.79e-05	0.00759	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—CDK1—thyroid cancer	6.79e-05	0.00759	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—CDK1—thyroid cancer	6.54e-05	0.00731	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—PTEN—thyroid cancer	6.49e-05	0.00726	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	6.33e-05	0.00708	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	6.27e-05	0.007	CbGpPWpGaD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.98e-05	0.00668	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.86e-05	0.00654	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	5.69e-05	0.00636	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	5.57e-05	0.00623	CbGpPWpGaD
Mexiletine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	5.54e-05	0.00619	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CDK1—thyroid cancer	5.27e-05	0.00589	CbGpPWpGaD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.13e-05	0.00573	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—RXRA—thyroid cancer	4.89e-05	0.00547	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	4.89e-05	0.00546	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CDK1—thyroid cancer	4.84e-05	0.00541	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CDK1—thyroid cancer	4.84e-05	0.00541	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	4.7e-05	0.00526	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CDK1—thyroid cancer	4.67e-05	0.00522	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—CDK1—thyroid cancer	4.6e-05	0.00514	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—RXRA—thyroid cancer	4.5e-05	0.00502	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—RXRA—thyroid cancer	4.5e-05	0.00502	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—thyroid cancer	4.43e-05	0.00495	CbGpPWpGaD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.34e-05	0.00485	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—RXRA—thyroid cancer	4.33e-05	0.00485	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	4.32e-05	0.00483	CbGpPWpGaD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.16e-05	0.00464	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.52e-05	0.00393	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.35e-05	0.00375	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.33e-05	0.00373	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CDK1—thyroid cancer	3.28e-05	0.00367	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	3.18e-05	0.00355	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—RXRA—thyroid cancer	3.11e-05	0.00348	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—PPARG—thyroid cancer	3.09e-05	0.00345	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—RXRA—thyroid cancer	3.05e-05	0.00341	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—PPARG—thyroid cancer	2.84e-05	0.00317	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PPARG—thyroid cancer	2.84e-05	0.00317	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—PPARG—thyroid cancer	2.74e-05	0.00306	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.72e-05	0.00304	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	2.67e-05	0.00298	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—thyroid cancer	2.65e-05	0.00296	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.5e-05	0.00279	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—thyroid cancer	2.43e-05	0.00272	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—thyroid cancer	2.43e-05	0.00272	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—thyroid cancer	2.35e-05	0.00262	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MINPP1—thyroid cancer	2.33e-05	0.00261	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MINPP1—thyroid cancer	2.29e-05	0.00255	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—thyroid cancer	2.28e-05	0.00255	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—RXRA—thyroid cancer	2.21e-05	0.00247	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—thyroid cancer	2.1e-05	0.00234	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—thyroid cancer	2.1e-05	0.00234	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	2.08e-05	0.00232	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—thyroid cancer	2.02e-05	0.00226	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.99e-05	0.00222	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	1.98e-05	0.00222	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NDUFA13—thyroid cancer	1.94e-05	0.00217	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—thyroid cancer	1.94e-05	0.00217	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PPARG—thyroid cancer	1.92e-05	0.00215	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—thyroid cancer	1.89e-05	0.00211	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—RXRA—thyroid cancer	1.87e-05	0.00209	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CHST14—thyroid cancer	1.87e-05	0.00208	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CHST14—thyroid cancer	1.83e-05	0.00204	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	1.79e-05	0.002	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—thyroid cancer	1.78e-05	0.00199	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—thyroid cancer	1.78e-05	0.00199	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—thyroid cancer	1.74e-05	0.00194	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—thyroid cancer	1.74e-05	0.00194	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—thyroid cancer	1.72e-05	0.00192	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—thyroid cancer	1.68e-05	0.00187	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—thyroid cancer	1.65e-05	0.00184	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—thyroid cancer	1.63e-05	0.00182	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MINPP1—thyroid cancer	1.62e-05	0.00181	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.52e-05	0.0017	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HPGD—thyroid cancer	1.5e-05	0.00168	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—thyroid cancer	1.5e-05	0.00167	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—thyroid cancer	1.5e-05	0.00167	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HPGD—thyroid cancer	1.47e-05	0.00165	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.44e-05	0.00161	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—thyroid cancer	1.44e-05	0.00161	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—thyroid cancer	1.42e-05	0.00159	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—thyroid cancer	1.38e-05	0.00155	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	1.38e-05	0.00154	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MINPP1—thyroid cancer	1.37e-05	0.00154	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CHST14—thyroid cancer	1.3e-05	0.00145	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—thyroid cancer	1.27e-05	0.00142	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—thyroid cancer	1.27e-05	0.00142	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—thyroid cancer	1.23e-05	0.00137	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—thyroid cancer	1.22e-05	0.00136	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—thyroid cancer	1.21e-05	0.00135	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—thyroid cancer	1.18e-05	0.00132	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	1.17e-05	0.00131	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—thyroid cancer	1.12e-05	0.00125	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—thyroid cancer	1.12e-05	0.00125	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CHST14—thyroid cancer	1.1e-05	0.00123	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—thyroid cancer	1.08e-05	0.00121	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.06e-05	0.00118	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HPGD—thyroid cancer	1.04e-05	0.00117	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—thyroid cancer	1.01e-05	0.00113	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	9.01e-06	0.00101	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HPGD—thyroid cancer	8.85e-06	0.000989	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TPR—thyroid cancer	8.64e-06	0.000965	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—thyroid cancer	8.62e-06	0.000963	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	8.5e-06	0.000949	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CHST14—thyroid cancer	8.48e-06	0.000947	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TPR—thyroid cancer	8.46e-06	0.000945	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	8.32e-06	0.00093	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—thyroid cancer	7.61e-06	0.00085	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.18e-06	0.000803	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPGD—thyroid cancer	6.83e-06	0.000764	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	6.46e-06	0.000722	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	6.33e-06	0.000708	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TPR—thyroid cancer	6e-06	0.000671	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	5.9e-06	0.00066	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—RXRA—thyroid cancer	5.43e-06	0.000607	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—RXRA—thyroid cancer	5.32e-06	0.000595	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TPR—thyroid cancer	5.08e-06	0.000568	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	5e-06	0.000559	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.53e-06	0.000507	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	4.49e-06	0.000502	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TPR—thyroid cancer	3.92e-06	0.000439	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	3.86e-06	0.000431	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	3.81e-06	0.000425	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—RXRA—thyroid cancer	3.77e-06	0.000422	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.57e-06	0.000399	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARG—thyroid cancer	3.43e-06	0.000383	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARG—thyroid cancer	3.36e-06	0.000375	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—RXRA—thyroid cancer	3.2e-06	0.000357	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.11e-06	0.000348	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.94e-06	0.000328	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—thyroid cancer	2.7e-06	0.000302	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—thyroid cancer	2.64e-06	0.000295	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—RXRA—thyroid cancer	2.47e-06	0.000276	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARG—thyroid cancer	2.38e-06	0.000266	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—thyroid cancer	2.35e-06	0.000263	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—thyroid cancer	2.3e-06	0.000258	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARG—thyroid cancer	2.02e-06	0.000226	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—thyroid cancer	1.87e-06	0.00021	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—thyroid cancer	1.64e-06	0.000183	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.59e-06	0.000178	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.56e-06	0.000174	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—thyroid cancer	1.39e-06	0.000155	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—thyroid cancer	1.36e-06	0.000152	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—thyroid cancer	1.33e-06	0.000148	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.23e-06	0.000137	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.07e-06	0.000119	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—thyroid cancer	9.42e-07	0.000105	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—thyroid cancer	7.98e-07	8.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—thyroid cancer	6.16e-07	6.89e-05	CbGpPWpGaD
